JP2019099537A - Method for producing nitrogen-containing heterocyclic compound - Google Patents
Method for producing nitrogen-containing heterocyclic compound Download PDFInfo
- Publication number
- JP2019099537A JP2019099537A JP2017235424A JP2017235424A JP2019099537A JP 2019099537 A JP2019099537 A JP 2019099537A JP 2017235424 A JP2017235424 A JP 2017235424A JP 2017235424 A JP2017235424 A JP 2017235424A JP 2019099537 A JP2019099537 A JP 2019099537A
- Authority
- JP
- Japan
- Prior art keywords
- general formula
- integer
- nitrogen
- containing heterocyclic
- atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 *C1=CC=CC(*c2ccccc2)=CC1 Chemical compound *C1=CC=CC(*c2ccccc2)=CC1 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N c1ccccc1 Chemical compound c1ccccc1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- ZSVOHYAILNMNFK-UHFFFAOYSA-N CCC(C)(C1)N1C1C2=CC12 Chemical compound CCC(C)(C1)N1C1C2=CC12 ZSVOHYAILNMNFK-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Catalysts (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Description
本発明は、有機合成化合物の有用な中間体、特に、有機エレクトロルミネッセンス用材料として有用なボレート化合物およびそれから誘導される含窒素複素環化合物の製造方法に関する。 The present invention relates to a useful intermediate of an organic synthetic compound, in particular, a borate compound useful as a material for organic electroluminescence and a method for producing a nitrogen-containing heterocyclic compound derived therefrom.
アザジベンゾフラン等の含窒素複素環化合物をボレート化する方法として、アザジベンゾフランをハロゲン化し、続いてピナコロンジボレートと反応する方法が記載されている(特許文献1参照)。もしくはハロゲン化したアザジベンゾフランをn−BuLi(以下、nBuLiともいう)と反応し、続いてイソプロポキシボロン酸ピナコールと反応する方法が記載されている(特許文献1参照)。前者は高価なPd触媒を使用し、Suzukiカップリングに由来する副生物が生成すること、後者はn-ブチルリチウムでアニオン化する際、複数の部位がアニオン化され副生物が生成すること等の問題があった。そのため、合成されたボレート化合物をアリールハライドとSuzukiカップリング反応させると収率が低下する、純度が低下する等の問題があった。 As a method of borate nitrogen-containing heterocyclic compounds such as azadibenzofuran, a method of halogenating azadibenzofuran and subsequently reacting with pinacolone diborate is described (see Patent Document 1). Alternatively, a method is disclosed in which a halogenated azadibenzofuran is reacted with n-BuLi (hereinafter also referred to as nBuLi) and subsequently reacted with isopropoxyboronic acid pinacol (see Patent Document 1). The former uses an expensive Pd catalyst and produces by-products derived from Suzuki coupling, and the latter, when anionizing with n-butyllithium, causes multiple sites to be anionized to produce by-products, etc. There was a problem. Therefore, when the synthesized borate compound is subjected to Suzuki coupling reaction with an aryl halide, there are problems such as a decrease in yield and a decrease in purity.
本発明は上記問題点を解決すべくなされたものであり、高収率、高純度で得られる含窒素複素環化合物の製造方法を提供することにある。 The present invention has been made to solve the above problems, and its object is to provide a method for producing a nitrogen-containing heterocyclic compound obtained in high yield and high purity.
上記課題は、以下の構成により解決することができた。 The above-mentioned subject was able to be solved by the following composition.
1.下記一般式[1]で表される化合物とn−BuLiでリチオ化し、さらに下記一般式[2]で表される化合物を反応させ下記一般式[3]で表される化合物を得ることを特徴とする含窒素複素環化合物の製造方法。 1. The compound represented by the following general formula [1] is lithiated with n-BuLi, and the compound represented by the following general formula [2] is further reacted to obtain the compound represented by the following general formula [3] Method for producing a nitrogen-containing heterocyclic compound
(式中、X1は酸素原子もしくは硫黄原子を表す。R1、R2は置換基を表す。A1〜A4はそれぞれ独立に、NもしくはCRを表し、Rは水素原子または置換基を表す。ただし、A1〜A4のNの数は1〜2である。m1は0〜2の整数、m2は0〜4の整数を表す。R3〜R5はそれぞれ独立に、アルキル基、シクロアルキル基、またはアリール基を表し、R4とR5で互いに結合して環を形成してもよい。) (Wherein, X 1 represents an oxygen atom or a sulfur atom. R 1 and R 2 represent a substituent. A 1 to A 4 each independently represent N or CR, and R represents a hydrogen atom or a substituent. However, the number of N of A 1 to A 4 is 1 to 2. m 1 is an integer of 0 to 2 and m 2 is an integer of 0 to 4. R 3 to R 5 are each independently Represents an alkyl group, a cycloalkyl group, or an aryl group, and R 4 and R 5 may combine with each other to form a ring)
2.前記n−BuLiの添加量が前記一般式[1]に対するモル比で0.85〜0.99であることを特徴とする前記1に記載の含窒素複素環化合物の製造方法。 2. The method for producing a nitrogen-containing heterocyclic compound according to the above 1, wherein the addition amount of the n-BuLi is 0.85 to 0.99 in molar ratio to the general formula [1].
3.前記一般式[1]で表される化合物と前記n−BuLiでリチオ化し、さらに前記一般式[2]で表される化合物を反応させる反応温度を−20℃〜10℃で行うことを特徴とする前記1または前記2に記載の含窒素複素環化合物の製造方法。 3. The reaction is carried out at a reaction temperature of −20 ° C. to 10 ° C., by which the compound represented by the general formula [1] is lithiated with the n-BuLi, and the compound represented by the general formula [2] is further reacted. A process for producing the nitrogen-containing heterocyclic compound according to 1 or 2 above.
4.前記一般式[1]が下記一般式[8]で表され、前記一般式[3]が下記一般式[9]で表されることを特徴とする前記1から前記3のいずれか一つに記載の含窒素複素環化合物の製造方法。 4. In any one of 1 to 3 above, the general formula [1] is represented by the following general formula [8], and the general formula [3] is represented by the following general formula [9] The manufacturing method of the nitrogen-containing heterocyclic compound as described.
(式中、X1は酸素原子もしくは硫黄原子を表す。R1、R2は置換基を表す。m1は0〜2の整数、m2は0〜4の整数を表す。R4、R5はそれぞれ独立に、アルキル基、シクロアルキル基、またはアリール基を表し、R4とR5で互いに結合して環を形成してもよい。) (Wherein, X 1 is .R 1, R 2 is an integer of .m 1 is 0 to 2 represents a substituent, m 2 is .R 4 represents an integer of 0 to 4 representing an oxygen atom or a sulfur atom, R 5 each independently represents an alkyl group, a cycloalkyl group or an aryl group, and R 4 and R 5 may combine with each other to form a ring)
5.前記1から前記4のいずれか一つに記載の含窒素複素環化合物の製造方法で製造された含窒素複素環化合物を精製することなく、下記一般式[4]で表される化合物と、Pd触媒およびホスフィンリガンドの存在下で反応させ下記一般式[5]で表される化合物を得ることを特徴とする含窒素複素環化合物の製造方法。
5. Without purifying the nitrogen-containing heterocyclic compound produced by the method for producing a nitrogen-containing heterocyclic compound according to any one of the
(式中、X1は酸素原子もしくは硫黄原子を表す。R1、R2およびR6は置換基を表す。A1〜A4はそれぞれ独立に、NもしくはCRを表し、Rは水素原子または置換基を表す。ただし、A1〜A4のNの数は1〜2である。m1は0〜2の整数、m2は0〜4の整数、m6は0〜4の整数を表す。X2は塩素原子、臭素原子、またはヨウ素原子を表す。n2は2〜4の整数を表す。) (Wherein, X 1 represents an oxygen atom or a sulfur atom. R 1 , R 2 and R 6 each represent a substituent. A 1 to A 4 each independently represent N or CR, and R represents a hydrogen atom or A represents a substituent, provided that the number of N in A 1 to A 4 is 1 to 2. m 1 is an integer of 0 to 2, m 2 is an integer of 0 to 4 and m 6 is an integer of 0 to 4 X 2 represents a chlorine atom, a bromine atom or an iodine atom, and n 2 represents an integer of 2 to 4.)
6.前記1から前記4のいずれか一つに記載の含窒素複素環化合物の製造方法で製造された含窒素複素環化合物を精製することなく、下記一般式[6]で表される化合物とPd触媒およびホスフィンリガンドの存在下で反応させ下記一般式[7]で表される化合物を得ることを特徴とする含窒素複素環化合物の製造方法。
6. The compound represented by the following general formula [6] and the Pd catalyst without purifying the nitrogen-containing heterocyclic compound produced by the method for producing a nitrogen-containing heterocyclic compound according to any one of the
(式中、X1は酸素原子もしくは硫黄原子を表す。R1、R2、R7およびR8は置換基を表す。A1〜A4はそれぞれ独立に、NもしくはCRを表し、Rは水素原子または置換基を表す。ただし、A1〜A4のNの数は1〜2である。m1は0〜2の整数、m2は0〜4の整数、m7、m8はそれぞれ独立に、0〜3の整数を表す。X3、X4はそれぞれ独立に、塩素原子、臭素原子、またはヨウ素原子を表す。n3、n4はそれぞれ独立に、1〜2の整数を表す。Aは単なる結合手もしくは2価の連結基を表す。) (Wherein, X 1 represents an oxygen atom or a sulfur atom. R 1 , R 2 , R 7 and R 8 represent a substituent. A 1 to A 4 each independently represent N or CR, and R represents H 1 represents a hydrogen atom or a substituent, provided that the number of N in A 1 to A 4 is 1 to 2. m 1 is an integer of 0 to 2, m 2 is an integer of 0 to 4, m 7 and m 8 are Each independently represents an integer of 0 to 3. X 3 and X 4 each independently represent a chlorine atom, a bromine atom or an iodine atom n 3 and n 4 each independently represent an integer of 1 to 2 A represents a simple bond or a divalent linking group.)
7.下記一般式[3]で表される化合物と下記一般式[4]で表される化合物をPd触媒およびホスフィンリガンドの存在下で反応させ下記一般式[5]で表される化合物を得ることを特徴とする含窒素複素環化合物の製造方法。 7. Reacting a compound represented by the following general formula [3] with a compound represented by the following general formula [4] in the presence of a Pd catalyst and a phosphine ligand to obtain a compound represented by the following general formula [5] The manufacturing method of the nitrogen-containing heterocyclic compound which is characterized.
(式中、X1は酸素原子もしくは硫黄原子を表す。R1、R2およびR6は置換基を表す。A1〜A4はそれぞれ独立に、NもしくはCRを表し、Rは水素原子または置換基を表す。ただし、A1〜A4のNの数は1〜2である。m1は0〜2の整数、m2は0〜4の整数、m6は0〜4の整数を表す。X2は塩素原子、臭素原子、またはヨウ素原子を表す。n2は2〜4の整数を表す。R4、R5はそれぞれ独立に、アルキル基、シクロアルキル基、またはアリール基を表し、R4とR5で互いに結合して環を形成してもよい。) (Wherein, X 1 represents an oxygen atom or a sulfur atom. R 1 , R 2 and R 6 each represent a substituent. A 1 to A 4 each independently represent N or CR, and R represents a hydrogen atom or A represents a substituent, provided that the number of N in A 1 to A 4 is 1 to 2. m 1 is an integer of 0 to 2, m 2 is an integer of 0 to 4 and m 6 is an integer of 0 to 4 X 2 represents a chlorine atom, a bromine atom or an iodine atom, n 2 represents an integer of 2 to 4. R 4 and R 5 each independently represent an alkyl group, a cycloalkyl group or an aryl group , R 4 and R 5 may combine with each other to form a ring.)
8.下記一般式[3]で表される化合物と下記一般式[6]で表される化合物をPd触媒およびホスフィンリガンドの存在下で反応させ下記一般式[7]で表される化合物を得ることを特徴とする含窒素複素環化合物の製造方法。 8. Reacting a compound represented by the following general formula [3] with a compound represented by the following general formula [6] in the presence of a Pd catalyst and a phosphine ligand to obtain a compound represented by the following general formula [7] The manufacturing method of the nitrogen-containing heterocyclic compound which is characterized.
(式中、X1は酸素原子もしくは硫黄原子を表す。R1、R2、R7およびR8は置換基を表す。A1〜A4はそれぞれ独立に、NもしくはCRを表し、Rは水素原子または置換基を表す。ただし、A1〜A4のNの数は1〜2である。m1は0〜2の整数、m2は0〜4の整数、m7、m8はそれぞれ独立に、0〜3の整数を表す。X3、X4はそれぞれ独立に、塩素原子、臭素原子、またはヨウ素原子を表す。n3、n4はそれぞれ独立に、1〜2の整数を表す。Aは単なる結合手もしくは2価の連結基を表す。R4、R5はそれぞれ独立に、アルキル基、シクロアルキル基、またはアリール基を表し、R4とR5で互いに結合して環を形成してもよい。) (Wherein, X 1 represents an oxygen atom or a sulfur atom. R 1 , R 2 , R 7 and R 8 represent a substituent. A 1 to A 4 each independently represent N or CR, and R represents H 1 represents a hydrogen atom or a substituent, provided that the number of N in A 1 to A 4 is 1 to 2. m 1 is an integer of 0 to 2, m 2 is an integer of 0 to 4, m 7 and m 8 are Each independently represents an integer of 0 to 3. X 3 and X 4 each independently represent a chlorine atom, a bromine atom or an iodine atom n 3 and n 4 each independently represent an integer of 1 to 2 A represents a simple bond or a divalent linking group R 4 and R 5 each independently represent an alkyl group, a cycloalkyl group or an aryl group, and R 4 and R 5 are bonded to each other to form a ring You may form
9.前記一般式[3]が下記一般式[9]で表されることを特徴とする前記7または前記8に記載の含窒素複素環化合物の製造方法。 9. 7. The method for producing a nitrogen-containing heterocyclic compound according to 7 or 8 above, wherein the general formula [3] is represented by the following general formula [9].
(式中、X1は酸素原子もしくは硫黄原子を表す。R1、R2は置換基を表す。m1は0〜2の整数、m2は0〜4の整数を表す。R4、R5はそれぞれ独立に、アルキル基、シクロアルキル基、またはアリール基を表し、R4とR5で互いに結合して環を形成してもよい。) (Wherein, X 1 is .R 1, R 2 is an integer of .m 1 is 0 to 2 represents a substituent, m 2 is .R 4 represents an integer of 0 to 4 representing an oxygen atom or a sulfur atom, R 5 each independently represents an alkyl group, a cycloalkyl group or an aryl group, and R 4 and R 5 may combine with each other to form a ring)
10.前記ホスフィンリガンドが下記一般式[10]で表されることを特徴とする前記5から前記9のいずれか一つに記載の含窒素複素環化合物の製造方法。
10. The method for producing a nitrogen-containing heterocyclic compound according to any one of the
(式中、R9〜R11はそれぞれ独立に、アルキル基、シクロアルキル基、またはアリール基を表す。) (Wherein, R 9 to R 11 each independently represent an alkyl group, a cycloalkyl group or an aryl group).
11.全ての反応を同一のエーテル系溶媒で行うことを特徴とする前記1から前記10のいずれか一つに記載の含窒素複素環化合物の製造方法。
11. 11. The method for producing a nitrogen-containing heterocyclic compound according to any one of the
12.全ての反応を1ポットで行うことを特徴とする前記1から前記11のいずれか一つに記載の含窒素複素環化合物の製造方法。 12. 11. The method for producing a nitrogen-containing heterocyclic compound according to any one of 1 to 11 above, wherein all the reaction is carried out in one pot.
本発明の含窒素複素環化合物の製造方法は、窒素複素環化合物を高収率、高純度で得ることができる。 The method for producing a nitrogen-containing heterocyclic compound of the present invention can obtain a nitrogen heterocyclic compound in high yield and high purity.
以下、本発明をさらに詳細に述べる。
図1に示すように、含窒素複素環化合物の製造方法は、リチオ化する工程S101と、一般式[3]で表される化合物を得る工程S102と、を含む。
Hereinafter, the present invention will be described in more detail.
As shown in FIG. 1, the method for producing a nitrogen-containing heterocyclic compound includes a step S101 of lithiation and a step S102 of obtaining a compound represented by the general formula [3].
含窒素複素環化合物の製造方法は、下記一般式[1]で表される化合物とn−BuLiでリチオ化し、さらに下記一般式[2]で表される化合物を反応させ下記一般式[3]で表される化合物を得るものである。
なお、一般式[3]で表される含窒素複素環化合物は、有機合成化合物の有用な中間体、特に、有機エレクトロルミネッセンス用材料として有用なボレート化合物である。
The method for producing a nitrogen-containing heterocyclic compound is a method represented by the following general formula [1] and n-BuLi, followed by reaction with a compound represented by the following general formula [2] to obtain a compound represented by the following general formula [3] To obtain the compound represented by
The nitrogen-containing heterocyclic compound represented by the general formula [3] is a useful intermediate of an organic synthetic compound, in particular, a borate compound useful as a material for organic electroluminescence.
一般式[1]〜[3]中、X1は酸素原子もしくは硫黄原子を表す。これらのうち好ましいものは、酸素原子である。 In the general formulas [1] to [3], X 1 represents an oxygen atom or a sulfur atom. Among these, preferred is an oxygen atom.
一般式[1]〜[3]中、R1、R2は置換基を表す。A1〜A4はそれぞれ独立に、NもしくはCRを表し、Rは水素原子または置換基を表す。ただし、A1〜A4のNの数は1〜2であり、好ましくは1である。 In the general formulas [1] to [3], R 1 and R 2 each represents a substituent. Each of A 1 to A 4 independently represents N or CR, and R represents a hydrogen atom or a substituent. However, the number of N of A 1 to A 4 is 1 to 2, preferably 1.
前記のR1、R2、Rで表される置換基としては、例えば、アルキル、シクロアルキル、アルケニル、アリール、アシルアミノ、スルホンアミド、アルキルチオ、アリールチオ、複素環(例えば、ジベンゾフラン環、アザジベンゾフラン環、ジベンゾジオフェン環、カルバゾール環等)、スルホニル、スルフィニル、ホスホニル、アシル、カルバモイル、スルファモイル、シアノ、アルコキシ、アリールオキシ、複素環オキシ、シロキシ、アシルオキシ、カルバモイルオキシ、アミノ、アルキルアミノ、イミド、ウレイド、スルファモイルアミノ、アルコキシカルボニルアミノ、アルコキシカルボニルアミノ、アリールオキシカルボニルアミノ、アルコキシカルボニル、アリールオキシカルボニル、カルボキシル、2−(2−ピリジル)フェニル等の各基が挙げられる。これらのうち好ましいものはアリール基である。 The substituent represented by R 1 , R 2 and R is, for example, alkyl, cycloalkyl, alkenyl, aryl, acylamino, sulfonamide, alkylthio, arylthio, heterocyclic ring (eg, dibenzofuran ring, azadibenzofuran ring, Dibenzodiophen ring, carbazole ring, etc.) sulfonyl, sulfinyl, phosphonyl, acyl, carbamoyl, sulfamoyl, cyano, alkoxy, aryloxy, heterocyclic oxy, siloxy, acyloxy, carbamoyloxy, amino, alkylamino, imide, ureido, sulul Famoylamino, alkoxycarbonylamino, alkoxycarbonylamino, aryloxycarbonylamino, alkoxycarbonyl, aryloxycarbonyl, carboxyl, 2- (2-pyridyl) phenyl Each group such as phenyl and the like can be mentioned. Among these, preferred is an aryl group.
一般式[1]〜[3]中、m1は0〜2の整数、m2は0〜4の整数を表す。R3〜R5はそれぞれ独立に、アルキル基、シクロアルキル基、またはアリール基を表し、好ましくはアルキル基である。
R4とR5で互いに結合して環を形成してもよく、好ましくはテトラメチルエチレン基である。
In general formulas [1] to [3], m 1 represents an integer of 0 to 2 , and m 2 represents an integer of 0 to 4. Each of R 3 to R 5 independently represents an alkyl group, a cycloalkyl group or an aryl group, preferably an alkyl group.
R 4 and R 5 may bond to each other to form a ring, preferably a tetramethylethylene group.
n−BuLiの添加量は、一般式[1]に対するモル比で0.85〜0.99であることが好ましい。この範囲であれば、一般式[3]で表される化合物をより高収率、高純度で得ることができる。さらに、一般式[5]で表される化合物および一般式[7]で表される化合物をより高収率、高純度で得ることができる。n−BuLiの添加量は、窒素複素環化合物をより高収率、高純度で得る観点から、一般式[1]に対するモル比でより好ましくは0.90以上であり、さらに好ましくは0.93である。また、n−BuLiの添加量は、窒素複素環化合物をより高収率、高純度で得る観点から、より好ましくは0.97以下である。すなわち、n−BuLiの添加量は、より好ましくは0.93〜0.99であり、さらに好ましくは0.93〜0.97である。 The addition amount of n-BuLi is preferably 0.85 to 0.99 in molar ratio to the general formula [1]. Within this range, the compound represented by the general formula [3] can be obtained in higher yield and high purity. Further, the compound represented by the general formula [5] and the compound represented by the general formula [7] can be obtained in higher yield and high purity. The amount of n-BuLi added is preferably 0.90 or more, more preferably 0.93 or more in terms of molar ratio to the general formula [1], from the viewpoint of obtaining a nitrogen heterocyclic compound with higher yield and high purity. It is. The amount of n-BuLi added is more preferably 0.97 or less from the viewpoint of obtaining the nitrogen heterocyclic compound in higher yield and high purity. That is, the addition amount of n-BuLi is more preferably 0.93 to 0.99, and still more preferably 0.93 to 0.97.
一般式[1]で表される化合物とn−BuLiでリチオ化し、さらに一般式[2]で表される化合物を反応させる反応温度を−20℃〜10℃で行うことが好ましい。反応温度が−20℃以上であれば、超低温の設備が不要であり、設備的な観点において好ましい。一方、反応温度が10℃以下であれば、副反応を抑制できる。反応温度は、設備的な観点から、より好ましくは−10℃以上である。また、反応温度は、副反応を抑制する観点から、好ましくは5℃以下である。すなわち、反応温度は、より好ましくは−10℃〜10℃であり、さらに好ましくは−10℃〜5℃である。 It is preferable to carry out the reaction temperature to which the compound represented by general formula [1] is lithiated with n-BuLi, and the compound represented by general formula [2] at -20 ° C to 10 ° C. If reaction temperature is -20 degreeC or more, the installation of ultra-low temperature is unnecessary and it is preferable from an installation viewpoint. On the other hand, if the reaction temperature is 10 ° C. or less, side reactions can be suppressed. The reaction temperature is more preferably −10 ° C. or more from the viewpoint of equipment. The reaction temperature is preferably 5 ° C. or less from the viewpoint of suppressing side reactions. That is, the reaction temperature is more preferably -10 ° C to 10 ° C, and still more preferably -10 ° C to 5 ° C.
前記一般式[1]は、下記一般式[8]で表されることが好ましい。また、前記一般式[3]は、下記一般式[9]で表されることが好ましい。 It is preferable that the said General formula [1] is represented by following General formula [8]. Moreover, it is preferable that the said General formula [3] is represented by following General formula [9].
一般式[8]、[9]中、X1は酸素原子もしくは硫黄原子を表す。
一般式[8]、[9]中、R1、R2は置換基を表す。
一般式[8]、[9]中、m1は0〜2の整数、m2は0〜4の整数を表す。
一般式[8]、[9]中、R4、R5はそれぞれ独立に、アルキル基、シクロアルキル基、またはアリール基を表し、R4とR5で互いに結合して環を形成してもよい。
In the general formulas [8] and [9], X 1 represents an oxygen atom or a sulfur atom.
In the general formulas [8] and [9], R 1 and R 2 each represent a substituent.
In general formulas [8] and [9], m 1 represents an integer of 0 to 2 , and m 2 represents an integer of 0 to 4.
In the general formulas [8] and [9], R 4 and R 5 each independently represent an alkyl group, a cycloalkyl group or an aryl group, and R 4 and R 5 may combine with each other to form a ring Good.
図2に示すように、含窒素複素環化合物の製造方法は、リチオ化する工程S101と、一般式[3]で表される化合物を得る工程S102と、一般式[5]で表される化合物を得る工程S103aと、を含む。 As shown in FIG. 2, in the method for producing a nitrogen-containing heterocyclic compound, a step S101 of lithiation, a step S102 of obtaining a compound represented by the general formula [3], and a compound represented by the general formula [5] And obtaining step S103a.
含窒素複素環化合物の製造方法は、前記一般式[3]で表される化合物と下記一般式[4]で表される化合物をPd触媒およびホスフィンリガンドの存在下で反応させ下記一般式[5]で表される化合物を得るものである。
なお、一般式[5]で表される含窒素複素環化合物は、有機合成化合物の有用な中間体である、一般式[3]で表される化合物から誘導される含窒素複素環化合物であり、特に有機エレクトロルミネッセンス用材料として有用な含窒素複素環化合物である。
The method for producing a nitrogen-containing heterocyclic compound is a reaction of a compound represented by the above general formula [3] and a compound represented by the following general formula [4] in the presence of a Pd catalyst and a phosphine ligand: ] The compound represented by these is obtained.
The nitrogen-containing heterocyclic compound represented by the general formula [5] is a nitrogen-containing heterocyclic compound derived from the compound represented by the general formula [3], which is a useful intermediate of organic synthetic compounds. In particular, nitrogen-containing heterocyclic compounds useful as materials for organic electroluminescence.
一般式[4]、[5]中、X1は酸素原子もしくは硫黄原子を表す。これらのうち好ましいものは、酸素原子である。
一般式[4]、[5]中、R1、R2およびR6は置換基を表す。A1〜A4はそれぞれ独立に、NもしくはCRを表し、Rは水素原子または置換基を表す。ただし、A1〜A4のNの数は1〜2であり、好ましくは1である。
In the general formulas [4] and [5], X 1 represents an oxygen atom or a sulfur atom. Among these, preferred is an oxygen atom.
In the general formulas [4] and [5], R 1 , R 2 and R 6 each represent a substituent. Each of A 1 to A 4 independently represents N or CR, and R represents a hydrogen atom or a substituent. However, the number of N of A 1 to A 4 is 1 to 2, preferably 1.
前記のR1、R2、R6、Rで表される置換基としては、例えば、一般式[1]〜[3]で説明した置換基と同様である。 The substituent groups represented by R 1, R 2, R 6 , R, for example, the same substituents as described in the general formula [1] to [3].
一般式[4]、[5]中、m1は0〜2の整数、m2は0〜4の整数、m6は0〜4の整数を表す。X2は塩素原子、臭素原子、またはヨウ素原子を表す。これらのうち好ましいものは、臭素原子およびヨウ素原子である。
一般式[4]、[5]中、n2は2〜4の整数を表し、好ましくは3である。
In general formulas [4] and [5], m 1 represents an integer of 0 to 2, m 2 represents an integer of 0 to 4, and m 6 represents an integer of 0 to 4. X 2 represents a chlorine atom, a bromine atom or an iodine atom. Among these, preferred are a bromine atom and an iodine atom.
In the general formulas [4] and [5], n2 represents an integer of 2 to 4, and is preferably 3.
なお、一般式[3]で表される化合物は、前記したとおり、一般式[1]で表される化合物とn−BuLiでリチオ化し、さらに一般式[2]で表される化合物を反応させて得たものを用いることができる。ただし、一般式[3]で表される化合物は、この方法以外の方法で得たものを用いることもできる。
なお、いずれの方法においても、得られた一般式[3]で表される化合物は、精製することなく、一般式[4]で表される化合物との反応に用いることができる。ただし、精製してから用いてもよい。
The compound represented by the general formula [3] is, as described above, lithiated with the compound represented by the general formula [1] and n-BuLi, and further reacted with the compound represented by the general formula [2] It is possible to use one obtained by However, as the compound represented by the general formula [3], those obtained by methods other than this method can also be used.
In any of the methods, the obtained compound represented by the general formula [3] can be used for the reaction with the compound represented by the general formula [4] without purification. However, it may be used after purification.
図3に示すように、含窒素複素環化合物の製造方法は、リチオ化する工程S101と、一般式[3]で表される化合物を得る工程S102と、一般式[7]で表される化合物を得る工程S103bと、を含む。 As shown in FIG. 3, in the method for producing a nitrogen-containing heterocyclic compound, a step S101 of lithiation, a step S102 of obtaining a compound represented by the general formula [3], and a compound represented by the general formula [7] And obtaining step S103b.
含窒素複素環化合物の製造方法は、前記一般式[3]で表される化合物と下記一般式[6]で表される化合物をPd触媒およびホスフィンリガンドの存在下で反応させ下記一般式[7]で表される化合物を得るものである。
なお、一般式[7]で表される含窒素複素環化合物は、有機合成化合物の有用な中間体である、一般式[3]で表される化合物から誘導される含窒素複素環化合物であり、特に有機エレクトロルミネッセンス用材料として有用な含窒素複素環化合物である。
The process for producing a nitrogen-containing heterocyclic compound is carried out by reacting the compound represented by the above general formula [3] with the compound represented by the following general formula [6] in the presence of a Pd catalyst and a phosphine ligand ] The compound represented by these is obtained.
The nitrogen-containing heterocyclic compound represented by the general formula [7] is a nitrogen-containing heterocyclic compound derived from the compound represented by the general formula [3], which is a useful intermediate of organic synthetic compounds. In particular, nitrogen-containing heterocyclic compounds useful as materials for organic electroluminescence.
一般式[6]、[7]中、X1は酸素原子もしくは硫黄原子を表す。これらのうち好ましいものは、酸素原子である。
一般式[6]、[7]中、R1、R2、R7およびR8は置換基を表す。A1〜A4はそれぞれ独立に、NもしくはCRを表し、Rは水素原子または置換基を表す。ただし、A1〜A4のNの数は1〜2であり、好ましくは1である。
In the general formulas [6] and [7], X 1 represents an oxygen atom or a sulfur atom. Among these, preferred is an oxygen atom.
In the general formulas [6] and [7], R 1 , R 2 , R 7 and R 8 each represent a substituent. Each of A 1 to A 4 independently represents N or CR, and R represents a hydrogen atom or a substituent. However, the number of N of A 1 to A 4 is 1 to 2, preferably 1.
前記のR1、R2、R7、R8、Rで表される置換基としては、例えば、一般式[1]〜[3]で説明した置換基と同様である。 The substituent groups represented by R 1, R 2, R 7 , R 8, R, for example, the same substituents as described in the general formula [1] to [3].
一般式[6]、[7]中、m1は0〜2の整数、m2は0〜4の整数、m7、m8はそれぞれ独立に、0〜3の整数を表す。X3、X4はそれぞれ独立に、塩素原子、臭素原子、またはヨウ素原子を表す。これらのうち好ましいものは、臭素原子およびヨウ素原子である。
一般式[6]、[7]中、n3、n4はそれぞれ独立に、1〜2の整数を表し、好ましくは1である。
In the general formulas [6] and [7], m 1 is an integer of 0 to 2, m 2 is an integer of 0 to 4 and m 7 and m 8 each independently represent an integer of 0 to 3. Each of X 3 and X 4 independently represents a chlorine atom, a bromine atom or an iodine atom. Among these, preferred are a bromine atom and an iodine atom.
In the general formulas [6] and [7], n 3 and n 4 each independently represent an integer of 1 to 2, preferably 1.
一般式[6]、[7]中、Aは単なる結合手もしくは2価の連結基を表す。単なる結合手とは、連結する置換基同士を直接結合する単なる結合手である。これらのうちで好ましいものは単なる結合手である。 In the general formulas [6] and [7], A represents a simple bond or a divalent linking group. The simple bond is a simple bond that directly bonds the substituents to be linked. Preferred among these are simple bonds.
Aで表される2価の連結基としては、アルキレン、アルケニレン、アルキニレン、アリーレン等の炭化水素基が挙げられる。Aで表される2価の連結基としては、前記の炭化水素基の他、ヘテロ原子を含むものであってもよく、またチオフェン−2,5−ジイル基やピラジン−2,3−ジイル基のような芳香族複素環を有する化合物(ヘテロ芳香族化合物ともいう)に由来する2価の連結基であってもよいし、酸素や硫黄等のカルコゲン原子であってもよい。また、アルキルイミノ基、ジアルキルシランジイル基やジアリールゲルマンジイル基のようなヘテロ原子を会して連結する基でもよい。 Examples of the divalent linking group represented by A include hydrocarbon groups such as alkylene, alkenylene, alkynylene and arylene. The divalent linking group represented by A may contain a hetero atom in addition to the above-mentioned hydrocarbon group, and may be a thiophene-2,5-diyl group or a pyrazine-2,3-diyl group. Or a divalent linking group derived from a compound having an aromatic heterocyclic ring (also referred to as a heteroaromatic compound) or a chalcogen atom such as oxygen or sulfur. Further, it may be a group which is linked via a hetero atom such as an alkylimino group, a dialkylsilanediyl group or a diarylgermandiyl group.
R7とR8が隣接する場合、Aと共に環を形成してもよい。 When R 7 and R 8 are adjacent to each other, they may form a ring with A.
なお、一般式[3]で表される化合物は、前記したとおり、一般式[1]で表される化合物とn−BuLiでリチオ化し、さらに一般式[2]で表される化合物を反応させて得たものを用いることができる。ただし、一般式[3]で表される化合物は、この方法以外の方法で得たものを用いることもできる。
なお、いずれの方法においても、得られた一般式[3]で表される化合物は、精製することなく、一般式[6]で表される化合物との反応に用いることができる。ただし、精製してから用いてもよい。
The compound represented by the general formula [3] is, as described above, lithiated with the compound represented by the general formula [1] and n-BuLi, and further reacted with the compound represented by the general formula [2] It is possible to use one obtained by However, as the compound represented by the general formula [3], those obtained by methods other than this method can also be used.
In any of the methods, the obtained compound represented by the general formula [3] can be used for the reaction with the compound represented by the general formula [6] without purification. However, it may be used after purification.
Pd触媒としては、例えばPdCl2、Pd(OAc)2、Pd(Pph3)4、PdCl2dppf、Pd(dba)2、Pd/c等が挙げられる。
Pd触媒の使用量は、一般式[4]もしくは一般式[6]で表される化合物 1molに対して0.01〜0.3molの範囲で用いることが好ましく、0.02〜0.2molの範囲で用いることが特に好ましい。
Examples of the Pd catalyst include PdCl 2 , Pd (OAc) 2 , Pd (Pph 3 ) 4 , PdCl 2 dppf, Pd (dba) 2 , Pd / c and the like.
The amount of Pd catalyst used is preferably in the range of 0.01 to 0.3 mol, and more preferably 0.02 to 0.2 mol, per mol of the compound represented by the general formula [4] or the general formula [6]. It is particularly preferred to use in the range.
ホスフィンリガンドとしては、トリアルキルホスフィン(例えば、トリn-ブチルホスフィン、トリt-ブチルホスフィン、トリシクロヘキシルホスフィン)、アリール基を少なくとも一つ有するホスフィン(例えば、トリフェニルホスフィン、SPHOS、XPHOS等)が挙げられる。これらのうち、好ましいものはアリール基を一つ有するホスフィンであり、特に好ましくはSPHOSである。 Examples of phosphine ligands include trialkyl phosphines (for example, tri n-butyl phosphine, tri t-butyl phosphine, tricyclohexyl phosphine), and phosphines having at least one aryl group (for example, triphenyl phosphine, SPHOS, XPHOS, etc.) Be Among these, phosphine having one aryl group is preferable, and SPHOS is particularly preferable.
ホスフィンリガンドは、一般式[4]もしくは一般式[6]で表される化合物 1molに対して0.01〜0.3molの範囲で用いることが好ましく、0.02〜0.2molの範囲で用いることが特に好ましい。 The phosphine ligand is preferably used in the range of 0.01 to 0.3 mol, more preferably 0.02 to 0.2 mol, per 1 mol of the compound represented by the general formula [4] or the general formula [6]. Is particularly preferred.
ホスフィンリガンドは、下記一般式[10]で表されることが好ましい。 The phosphine ligand is preferably represented by the following general formula [10].
一般式[10]中、R9〜R11はそれぞれ独立に、アルキル基、シクロアルキル基、またはアリール基を表す。
R9で表される基のうち、好ましいものはシクロアルキル基である。R10およびR11で表される基のうち、好ましいものはアルキル基である。
In the general formula [10], R 9 to R 11 each independently represent an alkyl group, a cycloalkyl group or an aryl group.
Among the groups represented by R 9 , preferred is a cycloalkyl group. Of the groups represented by R 10 and R 11 , preferred are alkyl groups.
上記反応には塩基を併用するのが好ましい。塩基としては、例えばアルカリ金属塩(炭酸ナトリウム、炭酸カリウム、炭酸水素ナトリウム、炭酸セシウム、フッ化セシウム、ナトリウムt-ブトキサイド等)、アミン誘導体(トリエチルアミン等)等が挙げられる。 It is preferable to use a base in combination in the above reaction. Examples of the base include alkali metal salts (sodium carbonate, potassium carbonate, sodium hydrogen carbonate, cesium carbonate, cesium fluoride, sodium t-butoxide and the like), amine derivatives (triethylamine and the like) and the like.
本発明における全ての反応は、同一の反応溶媒で行うことが好ましい。すなわち、一般式[1]で表される化合物とn−BuLiでリチオ化する反応と、その後の工程における化合物の反応は、同一の反応溶媒で行うことが好ましい。全ての反応を同一の反応溶媒で行うことで、経済性が向上する。
反応溶媒として、エーテル系溶媒が好ましく、例えばジエチルエーテル、ジイソプロピルエーテル、THF、エチレングリコールジメチルエーテル、エチレングリコールジエチルエーテル、1,4−ジオキサン等が挙げられる。これらのうち、好ましいものはTHFである。
It is preferred to carry out all reactions in the present invention with the same reaction solvent. That is, it is preferable that the reaction of lithiation with the compound represented by the general formula [1] and n-BuLi and the reaction of the compound in the subsequent steps be performed in the same reaction solvent. By performing all the reactions in the same reaction solvent, the economic efficiency is improved.
The reaction solvent is preferably an ether solvent, and examples thereof include diethyl ether, diisopropyl ether, THF, ethylene glycol dimethyl ether, ethylene glycol diethyl ether, 1,4-dioxane and the like. Of these, preferred is THF.
リチオ化で用いる溶媒の中に含まれる水分によりn−BuLiは速やかに分解する。このため、あらかじめ使用する溶媒の水分量をカールフィッシャー法等で測定し、分解するn−BuLiに相当する量を補正して添加することが好ましい。
カールフィッシャー法を用いた測定法には、容量滴定法と電量滴定法の2種類がある。容量滴定法は、試料をアルコールをベースにした溶剤に溶かし、KF試薬(ヨウ素、二酸化硫黄、塩基)と反応させ、KF試薬の消費した容量から試料の水分を求める。一方、電量滴定法は溶剤(アルコール、二酸化硫黄、塩基、ヨウ素イオン)に試料を溶かし、電界酸化によりヨウ素イオンをヨウ素に変え反応させ、電界酸化に消費した電気量から試料の水分量を測定する方法である。
N-BuLi is rapidly decomposed by the water contained in the solvent used for lithiation. For this reason, it is preferable to measure the water content of the solvent to be used in advance by the Karl-Fisher method or the like and correct the amount corresponding to n-BuLi to be decomposed and to add.
There are two types of measurement methods using the Karl Fischer method, volumetric titration and coulometric titration. In volumetric titration, a sample is dissolved in an alcohol-based solvent, reacted with KF reagent (iodine, sulfur dioxide, base), and the water content of the sample is determined from the volume consumed by the KF reagent. On the other hand, in the coulometric titration method, the sample is dissolved in a solvent (alcohol, sulfur dioxide, base, iodine ion), the iodine ion is converted to iodine by electric field oxidation and reacted, and the water content of the sample is measured from the amount of electricity consumed for electric field oxidation. It is a method.
本発明における全ての反応は、1ポットで行うことが好ましい。すなわち、一般式[1]で表される化合物とn−BuLiでリチオ化する反応と、その後の工程における化合物の反応は、1つの容器で行うことが好ましい。全ての反応を1ポットで行うことで、経済性が向上する。また、全ての反応を1ポットで行うことは、設備的な観点からも好ましい。 All reactions in the present invention are preferably performed in one pot. That is, it is preferable to carry out the reaction of lithiating the compound represented by the general formula [1] with n-BuLi and the reaction of the compound in the subsequent steps in one container. By performing all the reactions in one pot, the economic efficiency is improved. Moreover, it is preferable also from an equipment point of view to carry out all the reactions in one pot.
以下に、本発明の一般式[1]で表される化合物の代表的具体例を示すが、本発明はこれらに限定されものではない。 Hereinafter, representative specific examples of the compound represented by the general formula [1] of the present invention will be shown, but the present invention is not limited thereto.
以下に、本発明の一般式[2]で表される化合物の代表的具体例を示すが、本発明はこれらに限定されものではない。 Hereinafter, representative specific examples of the compound represented by the general formula [2] of the present invention will be shown, but the present invention is not limited thereto.
以下に、本発明の一般式[3]で表される化合物の代表的具体例を示すが、本発明はこれらに限定されものではない。 Hereinafter, representative specific examples of the compound represented by the general formula [3] of the present invention will be shown, but the present invention is not limited thereto.
以下に、本発明の一般式[4]で表される化合物の代表的具体例を示すが、本発明はこれらに限定されものではない。 Hereinafter, representative specific examples of the compound represented by the general formula [4] of the present invention will be shown, but the present invention is not limited thereto.
以下に、本発明の一般式[5]で表される化合物の代表的具体例を示すが、本発明はこれらに限定されものではない。 Hereinafter, representative specific examples of the compound represented by the general formula [5] of the present invention will be shown, but the present invention is not limited thereto.
以下に、本発明の一般式[6]で表される化合物の代表的具体例を示すが、本発明はこれらに限定されものではない。 Hereinafter, representative specific examples of the compound represented by the general formula [6] of the present invention will be shown, but the present invention is not limited thereto.
以下に、本発明の一般式[7]で表される化合物の代表的具体例を示すが、本発明はこれらに限定されものではない。 Hereinafter, representative specific examples of the compound represented by the general formula [7] of the present invention will be shown, but the present invention is not limited thereto.
以下に、本発明の一般式[10]で表される化合物の代表的具体例を示すが、本発明はこれらに限定されものではない。 Hereinafter, representative specific examples of the compound represented by the general formula [10] of the present invention will be shown, but the present invention is not limited thereto.
以下に実施例を挙げて本発明を具体的に説明するが、本発明の実施態様はこれらに限定されるものではない。 EXAMPLES The present invention will be specifically described by way of examples, but the embodiments of the present invention are not limited thereto.
実施例1(比較例)
《例示化合物5−3の合成》
Example 1 (comparative example)
Synthesis of Exemplified Compound 5-3
例示化合物1−1 16.9g(0.10mol)、2−イソプロポキシ−4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン 30.5g、AcOK 29.6g、DMSO 170mlを投入し窒素バブリングを20分間行った。この懸濁液にPdCl2dppf 8.2gを加え90℃で2時間加熱撹拌した。酢酸エチルを加え、水洗後減圧で溶媒除去した。カラムクロマトグラフィー(シリカゲル、展開液 酢酸エチル/トルエン)で精製し例示化合物3−1 16.2gを得た。例示化合物4−3 5.2gと、炭酸カリウム 9.2gを純水 19mlに溶解した溶液と、THF 480mlとを混ぜ、窒素バブリングを20分間行った。この懸濁液にPd(dba)2 1.5g、例示化合物10−1 1.0gを加え6時間還流した。水冷で5時間撹拌し析出した結晶を濾過、水洗、乾燥し、灰色結晶 7.7gを得た(収率23.9%、純度98.9%)。
例示化合物3−1および例示化合物5−3の構造は、1H NMRで確認した。
Exemplified compound 1-1 16.9 g (0.10 mol) of 2-isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 30.5 g, AcOK 29.6 g, and DMSO 170 ml are added. And bubbling nitrogen for 20 minutes. To this suspension, 8.2 g of PdCl 2 dppf was added, and the mixture was heated and stirred at 90 ° C. for 2 hours. Ethyl acetate was added, washed with water and then the solvent was removed under reduced pressure. The residue was purified by column chromatography (silica gel, developing solution: ethyl acetate / toluene) to obtain 16.2 g of Exemplified compound 3-1. A solution of 5.2 g of the exemplified compound 4 and 9.2 g of potassium carbonate dissolved in 19 ml of pure water and 480 ml of THF were mixed, and nitrogen bubbling was performed for 20 minutes. To this suspension, 1.5 g of Pd (dba) 2 and 1.0 g of the exemplified compound 10-1 were added, and the mixture was refluxed for 6 hours. The mixture was stirred for 5 hours under water cooling, and the precipitated crystals were filtered, washed with water and dried to obtain 7.7 g of gray crystals (yield: 23.9%, purity 98.9%).
The structures of Exemplified Compound 3-1 and Exemplified Compound 5-3 were confirmed by 1 H NMR.
例示化合物3−1 1H NMR (400MHz, CDCl3): 8.65 (d, 1H), 8.25 (d, 1H), 7.70 (d, 2H), 7.56 (t, 1H), 7.43 (t, 1H), 1.45 (s, 12H)
例示化合物5−3 1H NMR (400MHz, CDCl3): 8.84 (d, 3H), 8.78 (s, 3H), 8.36 (d, 3H), 7.77 (d, 3H), 7.70 (d, 3H), 7.63 (t, 3H), 7.52 (t, 3H)
Exemplary Compound 3-1 1 H NMR (400 MHz, CDCl 3): 8.65 (d, 1 H), 8. 25 (d, 1 H), 7. 70 (d, 2 H), 7.56 (t, 1 H), 7.43 (t, 1 H), 1.45 (s, 12H)
Exemplary Compound 5-3 1 H NMR (400 MHz, CDCl 3): 8.84 (d, 3 H), 8. 78 (s, 3 H), 8. 36 (d, 3 H), 7. 77 (d, 3 H), 7. 70 (d, 3 H), 7.63 (t, 3H), 7.52 (t, 3H)
実施例2(比較例)
《例示化合物5−3の合成》
Example 2 (comparative example)
Synthesis of Exemplified Compound 5-3
窒素気流下、例示化合物1−1 16.9g(0.10mol)を脱水THF 300mに溶解し、ドライアイス/アセトン浴で−70℃に冷却し、1.6M nBuLi 59.4ml(×0.95mol比 対例示化合物1−1)を10minで滴下した。室温で2時間撹拌した後、再び−70℃まで冷却し、I2 25.4gをTHF 50mlに溶解した溶液を10minで滴下し室温で2時間撹拌した。飽和食塩水で水洗し、溶媒を減圧で留去した。メタノール 100mlで再結晶を行い、ヨ−ド体 25.6gを得た。次に得られたヨード体 25.6gを脱水THF 250mに溶解し、ドライアイス/アセトン浴で−70℃に冷却し、1.6M nBuLi 51.1ml(×0.95mol比 対ヨード体)を10minで滴下した。室温で2時間撹拌した後、再び−70℃まで冷却し、例示化合物2−7 16.1gを10minで滴下し室温で1時間撹拌した。THF 450ml、例示化合物4−3 8.2g、炭酸カリウム 14.5gを純水 30mlに溶解した溶液の順に投入し、窒素バブリングを20分間行った。この懸濁液にPd(dba)2 2.3g、例示化合物10−1 1.6gを加え6時間還流した。水冷で5時間撹拌し析出した結晶を濾過、水洗、乾燥し、灰色結晶 9.8gを得た(収率55.9%、純度94.5%)。 In a nitrogen stream, 16.9 g (0.10 mol) of Exemplified Compound 1-1 is dissolved in 300 m of dehydrated THF, and cooled to -70 ° C. with a dry ice / acetone bath, and 59.4 ml of 1.6 M nBuLi (× 0.95 mol The comparative compound 1-1) was added dropwise over 10 minutes. After stirring at room temperature for 2 hours, the solution was cooled again to -70 ° C, and a solution of 25.4 g of I 2 dissolved in 50 ml of THF was added dropwise over 10 minutes and stirred at room temperature for 2 hours. The extract was washed with saturated brine and the solvent was evaporated under reduced pressure. Recrystallization was carried out with 100 ml of methanol to obtain 25.6 g of iodo compound. Next, 25.6 g of the obtained iodo compound is dissolved in 250 m of dehydrated THF, cooled to -70 ° C. with a dry ice / acetone bath, and 51.1 ml of 1.6 M nBuLi (× 0.95 molar ratio to iodine compound) for 10 min. It dripped at. The mixture was stirred at room temperature for 2 hours, cooled again to -70 ° C, 16.1 g of the exemplified compound 2-7 was added dropwise over 10 minutes, and stirred at room temperature for 1 hour. A solution of 450 ml of THF, 8.2 g of the exemplified compound 4-3, and 14.5 g of potassium carbonate dissolved in 30 ml of pure water was sequentially charged, and nitrogen bubbling was performed for 20 minutes. To this suspension, 2.3 g of Pd (dba) 2 and 1.6 g of the exemplified compound 10-1 were added, and the mixture was refluxed for 6 hours. The mixture was stirred for 5 hours under water cooling, and the precipitated crystals were filtered, washed with water and dried to obtain 9.8 g of gray crystals (yield 55.9%, purity 94.5%).
実施例3(本発明)
《例示化合物5−3の合成》
Example 3 (Invention)
Synthesis of Exemplified Compound 5-3
窒素気流下、例示化合物1−1 16.9g(0.10mol)を脱水THF 390mに溶解し、氷水浴で−5℃とし、1.6M nBuLi 59.4ml(×0.95mol比 対例示化合物1−1)を10minで滴下した(THFの含水量を電量滴定法で測定したところ15ppmであった。これは、水分子 3.25×10−4molに当たり、相当する量の1.6M nBuLi溶液 0.20mlを補正量として上乗せして加えた。)。1時間撹拌した後、例示化合物2−7 18.6gを10minで滴下し1時間撹拌した。この間、内温は−10℃〜10℃であった。THF 480ml、例示化合物4−3 9.5g、炭酸カリウム 16.8gを純水 30mlに溶解した溶液の順に投入し窒素バブリングを20分間行った。この懸濁液にPd(dba)2 2.7g、例示化合物10−1 1.8gを加え6時間還流した。水冷で5時間撹拌し析出した結晶を濾過、水洗、乾燥し、灰色結晶 14.4gを得た(収率82.0%、純度99.0%)。 In a nitrogen stream, 16.9 g (0.10 mol) of Exemplified Compound 1-1 is dissolved in 390 m of dehydrated THF, adjusted to −5 ° C. with an ice water bath, and 59.4 ml of 1.6 M nBuLi (× 0.95 mol ratio to Exemplified Compound 1 -1) was added dropwise over 10 min (the water content of THF was measured by coulometric titration and was 15 ppm. This corresponds to a corresponding amount of 1.6 M nBuLi solution per 3.25 × 10 −4 mol of water molecules. 0.20 ml was added as a correction amount. After stirring for 1 hour, 18.6 g of the exemplified compound 2-7 was added dropwise over 10 minutes and stirred for 1 hour. During this time, the internal temperature was -10 ° C to 10 ° C. A solution of 480 ml of THF, 9.5 g of the exemplified compound 4-3, and 16.8 g of potassium carbonate dissolved in 30 ml of pure water was sequentially charged, and nitrogen bubbling was performed for 20 minutes. To this suspension, 2.7 g of Pd (dba) 2 and 1.8 g of the exemplified compound 10-1 were added, and the mixture was refluxed for 6 hours. The precipitated crystals were filtered, washed with water and dried to obtain 14.4 g of gray crystals (yield 82.0%, purity 99.0%).
実施例4(本発明)
《例示化合物5−3の合成》
Example 4 (invention)
Synthesis of Exemplified Compound 5-3
窒素気流下、例示化合物1−1 16.9g(0.10mol)を脱水THF 390mに溶解し、氷水浴で−5℃とし、1.6M nBuLi 59.4ml(×0.95mol比 対例示化合物1−1)を10minで滴下した(THFの含水量を電量滴定法で測定したところ15ppmであった。これは、水分子 3.25×10−4molに当たり、相当する量の1.6M nBuLi溶液 0.20mlを補正量として上乗せして加えた。)。1時間撹拌した後、例示化合物2−7 18.6gを10minで滴下し1時間撹拌した。この間、内温は−10℃〜5℃であった。THF 480ml、例示化合物4−3 9.5g、炭酸カリウム 16.8gを純水 30mlに溶解した溶液の順に投入し窒素バブリングを20分間行った。この懸濁液にPd(dba)2 2.7g、例示化合物10−1 1.8gを加え6時間還流した。水冷で5時間撹拌し析出した結晶を濾過、水洗、乾燥し、灰色結晶 15.0gを得た(収率85.2%、純度99.5%)。 In a nitrogen stream, 16.9 g (0.10 mol) of Exemplified Compound 1-1 is dissolved in 390 m of dehydrated THF, adjusted to −5 ° C. with an ice water bath, and 59.4 ml of 1.6 M nBuLi (× 0.95 mol ratio to Exemplified Compound 1 -1) was added dropwise over 10 min (the water content of THF was measured by coulometric titration and was 15 ppm. This corresponds to a corresponding amount of 1.6 M nBuLi solution per 3.25 × 10 −4 mol of water molecules. 0.20 ml was added as a correction amount. After stirring for 1 hour, 18.6 g of the exemplified compound 2-7 was added dropwise over 10 minutes and stirred for 1 hour. During this time, the internal temperature was -10 ° C to 5 ° C. A solution of 480 ml of THF, 9.5 g of the exemplified compound 4-3, and 16.8 g of potassium carbonate dissolved in 30 ml of pure water was sequentially charged, and nitrogen bubbling was performed for 20 minutes. To this suspension, 2.7 g of Pd (dba) 2 and 1.8 g of the exemplified compound 10-1 were added, and the mixture was refluxed for 6 hours. The mixture was stirred for 5 hours under water cooling, and the precipitated crystals were filtered, washed with water and dried to obtain 15.0 g of gray crystals (yield 85.2%, purity 99.5%).
実施例5(本発明)
《例示化合物5−3の合成》
Example 5 (Invention)
Synthesis of Exemplified Compound 5-3
実施例4において例示化合物1−1に対するnBuLiのモル比を表1に示すように変化した時の収率と純度を表1に示す。また、モル比と純度の関係を図4に示す。なお、このモル比以外は実施例4と同様である。なお、純度はHPLCで下記の条件で測定した。 The yield and the purity when the molar ratio of nBuLi to the exemplified compound 1-1 in Example 4 is changed as shown in Table 1 are shown in Table 1. The relationship between the molar ratio and the purity is shown in FIG. In addition, it is the same as that of Example 4 except this molar ratio. The purity was measured by HPLC under the following conditions.
[HPCL条件]
カラム GL Sciences Inc. Inertsil ODS-3 5μm φ4.6mm x 250mm
展開溶媒 CH2Cl2/アセトニトリル 10/90 vol/vol
オーブン温度 40℃
検出波長 254nm
流速 1ml/min
[HPCL condition]
Column GL Sciences Inc. Inertsil ODS-3 5μm φ4.6mm x 250mm
Eluent CH 2 Cl 2 / acetonitrile 10/90 vol / vol
Oven temperature 40 ° C
Detection wavelength 254 nm
この結果を表1および図4に示す。 The results are shown in Table 1 and FIG.
表1および図4に示すように、モル比で0.85〜0.99は、収率、純度共に高いことが分かる。 As shown in Table 1 and FIG. 4, 0.85 to 0.99 in molar ratio is found to be high in both yield and purity.
実施例6(本発明)
《例示化合物5−3の合成》
Example 6 (invention)
Synthesis of Exemplified Compound 5-3
窒素気流下、例示化合物1−1 16.9g(0.10mol)を脱水THF 390mに溶解し、氷水浴で−5℃とし、1.6M nBuLi 59.4ml(×0.95mol比 対例示化合物1−1)を10minで滴下した(THFの含水量を電量滴定法で測定したところ15ppmであった。これは、水分子 3.25×10−4molに当たり、相当する量の1.6M nBuLi溶液 0.20mlを補正量として上乗せして加えた。)。1時間撹拌した後、例示化合物2−7 18.6gを10minで滴下し1時間撹拌した。この間、内温は−10℃〜5℃であった。THF 480ml、例示化合物4−3 9.5g、炭酸カリウム 16.8gを純水 30mlに溶解した溶液の順に投入し窒素バブリングを20分間行った。この懸濁液にPdCl2dppf 3.7gを加え6時間還流した。水冷で5時間撹拌し析出した結晶を濾過、水洗、乾燥し、灰色結晶 13.2gを得た(収率75.2%、純度98.0%)。 In a nitrogen stream, 16.9 g (0.10 mol) of Exemplified Compound 1-1 is dissolved in 390 m of dehydrated THF, adjusted to −5 ° C. with an ice water bath, and 59.4 ml of 1.6 M nBuLi (× 0.95 mol ratio to Exemplified Compound 1 -1) was added dropwise over 10 min (the water content of THF was measured by coulometric titration and was 15 ppm. This corresponds to a corresponding amount of 1.6 M nBuLi solution per 3.25 × 10 −4 mol of water molecules. 0.20 ml was added as a correction amount. After stirring for 1 hour, 18.6 g of the exemplified compound 2-7 was added dropwise over 10 minutes and stirred for 1 hour. During this time, the internal temperature was -10 ° C to 5 ° C. A solution of 480 ml of THF, 9.5 g of the exemplified compound 4-3, and 16.8 g of potassium carbonate dissolved in 30 ml of pure water was sequentially charged, and nitrogen bubbling was performed for 20 minutes. 3.7 g of PdCl 2 dppf was added to this suspension and refluxed for 6 hours. The mixture was stirred for 5 hours under water cooling, and the precipitated crystals were filtered, washed with water and dried to obtain 13.2 g of gray crystals (yield 75.2%, purity 98.0%).
実施例7(本発明)
《例示化合物5−3の合成》
Example 7 (Invention)
Synthesis of Exemplified Compound 5-3
窒素気流下、例示化合物1−1 16.9g(0.10mol)を脱水THF 390mに溶解し、氷水浴で−5℃とし、1.6M nBuLi 59.4ml(×0.95mol比 対例示化合物1−1)を10minで滴下した(THFの含水量を電量滴定法で測定したところ15ppmであった。これは、水分子 3.25×10−4molに当たり、相当する量の1.6M nBuLi溶液 0.20mlを補正量として上乗せして加えた。)。1時間撹拌した後、例示化合物2−7 18.6gを10minで滴下し1時間撹拌した。この間、内温は−10℃〜5℃であった。THF 480ml、例示化合物4−3 9.5g、炭酸カリウム 16.8gを純水 30mlに溶解した溶液の順に投入し窒素バブリングを20分間行った。この懸濁液にPd(dba)2 2.7g、XPhos 2.2gを加え6時間還流した。水冷で5時間撹拌し析出した結晶を濾過、水洗、乾燥し、灰色結晶 12.8gを得た(収率73.2%、純度98.1%)。 In a nitrogen stream, 16.9 g (0.10 mol) of Exemplified Compound 1-1 is dissolved in 390 m of dehydrated THF, adjusted to −5 ° C. with an ice water bath, and 59.4 ml of 1.6 M nBuLi (× 0.95 mol ratio to Exemplified Compound 1 -1) was added dropwise over 10 min (the water content of THF was measured by coulometric titration and was 15 ppm. This corresponds to a corresponding amount of 1.6 M nBuLi solution per 3.25 × 10 −4 mol of water molecules. 0.20 ml was added as a correction amount. After stirring for 1 hour, 18.6 g of the exemplified compound 2-7 was added dropwise over 10 minutes and stirred for 1 hour. During this time, the internal temperature was -10 ° C to 5 ° C. A solution of 480 ml of THF, 9.5 g of the exemplified compound 4-3, and 16.8 g of potassium carbonate dissolved in 30 ml of pure water was sequentially charged, and nitrogen bubbling was performed for 20 minutes. To this suspension, 2.7 g of Pd (dba) 2 and 2.2 g of XPhos were added and refluxed for 6 hours. The precipitated crystals were filtered, washed with water and dried to obtain 12.8 g of gray crystals (yield 73.2%, purity 98.1%).
実施例8(本発明)
《例示化合物5−5の合成》
Example 8 (Invention)
Synthesis of Exemplified Compound 5-5
窒素気流下、例示化合物1−1 16.9g(0.10mol)を脱水THF 390mに溶解し、氷水浴で−5℃とし、1.6M nBuLi 59.4ml(×0.95mol比 対例示化合物1−1)を10minで滴下した(THFの含水量を電量滴定法で測定したところ15ppmであった。これは、水分子 3.25×10−4molに当たり、相当する量の1.6M nBuLi溶液0.20mlを補正量として上乗せして加えた。)。1時間撹拌した後、例示化合物2−7 18.6gを10minで滴下し1時間撹拌した。この間、内温は−10℃〜5℃であった。THF 480ml、例示化合物4−5 9.5g、炭酸カリウム 16.8gを純水30mlに溶解した溶液の順に投入し窒素バブリングを20分間行った。この懸濁液にPd(dba)2 2.7g、例示化合物10−1 1.8gを加え6時間還流した。飽和食塩水で洗浄後、溶媒を減圧留去した。シクロヘキサンで再結晶を行い灰色結晶 14.2gを得た(収率81%、純度99.3%)。
例示化合物5−5の構造は、1H NMRで確認した。
In a nitrogen stream, 16.9 g (0.10 mol) of Exemplified Compound 1-1 is dissolved in 390 m of dehydrated THF, adjusted to −5 ° C. with an ice water bath, and 59.4 ml of 1.6 M nBuLi (× 0.95 mol ratio to Exemplified Compound 1 -1) was added dropwise over 10 min (the water content of THF was measured by coulometric titration and was 15 ppm. This corresponds to a corresponding amount of 1.6 M nBuLi solution per 3.25 × 10 −4 mol of water molecules. 0.20 ml was added as a correction amount. After stirring for 1 hour, 18.6 g of the exemplified compound 2-7 was added dropwise over 10 minutes and stirred for 1 hour. During this time, the internal temperature was -10 ° C to 5 ° C. A solution of 480 ml of THF, 9.5 g of the exemplified compound 4-5, and 16.8 g of potassium carbonate dissolved in 30 ml of pure water was sequentially charged, and nitrogen bubbling was performed for 20 minutes. To this suspension, 2.7 g of Pd (dba) 2 and 1.8 g of the exemplified compound 10-1 were added, and the mixture was refluxed for 6 hours. After washing with saturated brine, the solvent was evaporated under reduced pressure. Recrystallization with cyclohexane gave 14.2 g of gray crystals (yield 81%, purity 99.3%).
The structure of the exemplary compound 5-5 was confirmed by 1 H NMR.
例示化合物5−5 1H NMR (400MHz, CDCl3): 8.80 (d, 1H), 8.47-8.43 (m, 3H), 8.40 (d, 1H), 8.33 (d, 1H), 8.16 (d, 2H), 8.07 (d, 1H), 7.73-7.65 (m, 2H), 7.62 (t, 1H), 7.55-7.46 (m, 3H), 7.40 (t, 2H), 7.30-7.15 (m, 4H) Exemplified compound 5-5 1 H NMR (400 MHz, CDCl 3): 8.80 (d, 1 H), 8. 47-8. 43 (m, 3 H), 8. 40 (d, 1 H), 8.33 (d, 1 H), 8. 16 (d, 2 H) , 8.07 (d, 1H), 7.73-7.65 (m, 2H), 7.62 (t, 1H), 7.55-7.46 (m, 3H), 7.40 (t, 2H), 7.30-7.15 (m, 4H)
実施例9(本発明)
《例示化合物5−4の合成》
Example 9 (Invention)
Synthesis of Exemplified Compound 5-4
窒素気流下、例示化合物1−5 24.5g(0.10mol)を脱水THF 390mに溶解し、氷水浴出−5℃とし、1.6M nBuLi 59.4ml(×0.95mol比 対例示化合物1−5)を10minで滴下した(THFの含水量を電量滴定法で測定したところ15ppmであった。これは、水分子 3.25×10−4molに当たり、相当する量の1.6M nBuLi溶液 0.20mlを補正量として上乗せして加えた。)。1時間撹拌した後、例示化合物2−7 18.6gを10minで滴下し1時間撹拌した。この間、内温は−10℃〜5℃であった。THF 480ml、例示化合物4−3 9.5g、炭酸カリウム 16.8gを純水 30mlに溶解した溶液の順に投入し窒素バブリングを20分間行った。この懸濁液にPd(dba)2 2.7g、例示化合物10−1 1.8gを加え6時間還流した。水冷で5時間撹拌し析出した結晶を濾過、水洗、乾燥し、灰色結晶 20.4gを得た(収率83.2%、純度99.5%)。
例示化合物5−4の構造は、1H NMRで確認した。
In a nitrogen stream, 24.5 g (0.10 mol) of Exemplified Compound 1-5 is dissolved in 390 m of dehydrated THF, and the ice water bath is put at −5 ° C., 59.4 ml of 1.6 M nBuLi (× 0.95 mol ratio to
The structure of the exemplary compound 5-4 was confirmed by 1 H NMR.
例示化合物5−4 1H NMR (400MHz, CDCl3): 9.14 (s, 3H), 8.76 (d, 3H), 8.31 (d, 3H), 7.74-7.68 (m, 12H), 7.58 (t, 3H), 7.08 (t, 3H), 6.97 (t, 6H) Exemplary Compound 5-4 1 H NMR (400 MHz, CDCl 3): 9.14 (s, 3 H), 8. 76 (d, 3 H), 8.31 (d, 3 H), 7.74-7. 68 (m, 12 H), 7.58 (t, 3 H) , 7.08 (t, 3H), 6.97 (t, 6H)
実施例10(本発明)
《例示化合物7−1の合成》
Example 10 (Invention)
Synthesis of Exemplified Compound 7-1
窒素気流下、例示化合物1−1 16.9g(0.10mol)を脱水THF 390mに溶解し、氷水浴で−5℃とし、1.6M nBuLi 59.4ml(×0.95mol比 対例示化合物1−1)を10minで滴下した(THFの含水量を電量滴定法で測定したところ15ppmであった。これは、水分子 3.25×10−4molに当たり、相当する量の1.6M nBuLi溶液 0.20mlを補正量として上乗せして加えた。)。1時間撹拌した後、例示化合物2−7 18.6gを10minで滴下し1時間撹拌した。この間、内温は−10℃〜5℃であった。THF 480ml、例示化合物6−1 14.2g、炭酸カリウム 18.8gを純水 30mlに溶解した溶液の順に投入し窒素バブリングを20分間行った。この懸濁液にPd(dba)2 2.7g、例示化合物10−1 1.8gを加え6時間還流した。水冷で5時間撹拌し析出した結晶を濾過、水洗、乾燥し、灰色結晶 19.1gを得た(収率86.2%、純度99.5%)。
例示化合物7−1の構造は、1H NMRで確認した。
In a nitrogen stream, 16.9 g (0.10 mol) of Exemplified Compound 1-1 is dissolved in 390 m of dehydrated THF, adjusted to −5 ° C. with an ice water bath, and 59.4 ml of 1.6 M nBuLi (× 0.95 mol ratio to Exemplified Compound 1 -1) was added dropwise over 10 min (the water content of THF was measured by coulometric titration and was 15 ppm. This corresponds to a corresponding amount of 1.6 M nBuLi solution per 3.25 × 10 −4 mol of water molecules. 0.20 ml was added as a correction amount. After stirring for 1 hour, 18.6 g of the exemplified compound 2-7 was added dropwise over 10 minutes and stirred for 1 hour. During this time, the internal temperature was -10 ° C to 5 ° C. A solution of 480 ml of THF, 14.2 g of Exemplified Compound 6-1, and 18.8 g of potassium carbonate dissolved in 30 ml of pure water was sequentially charged, and nitrogen bubbling was performed for 20 minutes. To this suspension, 2.7 g of Pd (dba) 2 and 1.8 g of the exemplified compound 10-1 were added, and the mixture was refluxed for 6 hours. The precipitated crystals were filtered, washed with water and dried to obtain 19.1 g of gray crystals (yield 86.2%, purity 99.5%).
The structure of the exemplary compound 7-1 was confirmed by 1 H NMR.
例示化合物7−1 1H NMR (400MHz, CDCl3): 8.74 (d, 2H), 8.31 (d, 2H), 8.20 (d, 4H), 7.93 (d, 4H), 7.74-7.61 (m, 6H), 7.50 (t, 2H) Exemplary Compound 7-1 1 H NMR (400 MHz, CDCl 3): 8.74 (d, 2 H), 8.31 (d, 2 H), 8. 20 (d, 4 H), 7. 93 (d, 4 H), 7.74-7.61 (m, 6 H) , 7.50 (t, 2H)
実施例11(本発明)
《例示化合物7−2の合成》
Example 11 (present invention)
Synthesis of Exemplified Compound 7-2
窒素気流下、例示化合物1−5 24.5g(0.10mol)を脱水THF 390mに溶解し、氷水浴で−5℃とし、1.6M nBuLi 59.4ml(×0.95mol比 対例示化合物1−5)を10minで滴下した(THFの含水量を電量滴定法で測定したところ15ppmであった。これは、水分子 3.25×10−4molに当たり、相当する量の1.6M nBuLi溶液 0.20mlを補正量として上乗せして加えた。)。1時間撹拌した後、例示化合物2−7 18.6gを10minで滴下し1時間撹拌した。この間、内温は−10℃〜5℃であった。THF 480ml、例示化合物6−1 14.2g、炭酸カリウム 18.8gを純水 30mlに溶解した溶液の順に投入し窒素バブリングを20分間行った。この懸濁液にPd(dba)2 2.7g、例示化合物10−1 1.8gを加え6時間還流した。水冷で5時間撹拌し析出した結晶を濾過、水洗、乾燥し、灰色結晶 24.9gを得た(収率85.5%、純度99.5%)。
例示化合物7−2の構造は、1H NMRで確認した。
In a nitrogen stream, 24.5 g (0.10 mol) of Exemplified Compound 1-5 is dissolved in 390 m of dehydrated THF, adjusted to −5 ° C. with an ice water bath, and 59.4 ml of 1.6 M nBuLi (× 0.95 mol ratio to
The structure of Exemplified Compound 7-2 was confirmed by 1 H NMR.
例示化合物7−2 1H NMR (400MHz, CDCl3): 8.78 (d, 2H), 8.31 (d, 2H), 8.23 (d, 4H), 8.00 (d, 4H), 7.89 (d, 4H), 7.80 (d, 2H), 7.69 (d, 2H), 7.63-7.57 (m, 6H), 7.48 (t, 2H) Exemplified compound 7-2 1 H NMR (400 MHz, CDCl 3): 8.78 (d, 2 H), 8.31 (d, 2 H), 8.23 (d, 4 H), 8.00 (d, 4 H), 7. 89 (d, 4 H), 7.80 (d, 2H), 7.69 (d, 2H), 7.63-7.57 (m, 6H), 7.48 (t, 2H)
実施例12(本発明)
《例示化合物7−4の合成》
Example 12 (Invention)
Synthesis of Exemplified Compound 7-4
窒素気流下、例示化合物1−10 24.5g(0.10mol)を脱水THF 390mに溶解し、氷水浴で−5℃とし、1.6M nBuLi 59.4ml(×0.95mol比 対例示化合物1−10)を10minで滴下した(THFの含水量を電量滴定法で測定したところ15ppmであった。これは、水分子 3.25×10−4molに当たり、相当する量の1.6M nBuLi溶液 0.20mlを補正量として上乗せして加えた。)。1時間撹拌した後、例示化合物2−7 18.6gを10minで滴下し1時間撹拌した。この間、内温は−10℃〜5℃であった。THF 480ml、例示化合物6−1 14.2g、炭酸カリウム 18.8gを純水 30mlに溶解した溶液の順に投入し窒素バブリングを20分間行った。この懸濁液にPd(dba)2 2.7g、例示化合物10−1 1.8gを加え6時間還流した。水冷で5時間撹拌し析出した結晶を濾過、水洗、乾燥し、灰色結晶 24.6gを得た(収率84.5%、純度99.4%)。
例示化合物7−4の構造は、1H NMRで確認した。
In a nitrogen stream, 24.5 g (0.10 mol) of Exemplified Compound 1-10 is dissolved in 390 m of dehydrated THF, adjusted to -5 ° C. with an ice water bath, and 59.4 ml of 1.6 M nBuLi (× 0.95 mol ratio to Exemplified Compound 1 -10) was added dropwise over 10 minutes (the water content of THF was determined by coulometric titration to be 15 ppm. This corresponds to a corresponding amount of 1.6 M nBuLi solution per 3.25 × 10 −4 mol of water molecules. 0.20 ml was added as a correction amount. After stirring for 1 hour, 18.6 g of the exemplified compound 2-7 was added dropwise over 10 minutes and stirred for 1 hour. During this time, the internal temperature was -10 ° C to 5 ° C. A solution of 480 ml of THF, 14.2 g of Exemplified Compound 6-1, and 18.8 g of potassium carbonate dissolved in 30 ml of pure water was sequentially charged, and nitrogen bubbling was performed for 20 minutes. To this suspension, 2.7 g of Pd (dba) 2 and 1.8 g of the exemplified compound 10-1 were added, and the mixture was refluxed for 6 hours. The precipitated crystals were filtered, washed with water and dried to obtain 24.6 g of gray crystals (yield: 84.5%, purity: 99.4%).
The structure of the exemplary compound 7-4 was confirmed by 1 H NMR.
例示化合物7−4 1H NMR (400MHz, CF3COOD): 9.32 (d, 2H), 9.10 (s, 2H), 9.00 (d, 4H), 8.86 (d, 2H), 8.78 (d, 2H), 8.66 (d, 4H), 8.55 (d, 2H), 8.22 (d, 4H), 8.06 (t, 4H), 7.97 (d, 2H) Exemplary Compound 7-4 1 H NMR (400 MHz, CF 3 COOD): 9.32 (d, 2 H), 9. 10 (s, 2 H), 9.00 (d, 4 H), 8. 86 (d, 2 H), 8. 78 (d, 2 H), 8. 66 (d, 4H), 8.55 (d, 2H), 8.22 (d, 4H), 8.06 (t, 4H), 7.97 (d, 2H)
実施例13(本発明)
《例示化合物7−6の合成》
Example 13 (Invention)
Synthesis of Exemplified Compound 7-6
窒素気流下、例示化合物1−2 16.9g(0.10mol)を脱水THF 390mに溶解し、氷水浴で−5℃とし、1.6M nBuLi 59.4ml(×0.95mol比 対例示化合物1−2)を10minで滴下した(THFの含水量を電量滴定法で測定したところ15ppmであった。これは、水分子 3.25×10−4molに当たり、相当する量の1.6M nBuLi溶液 0.20mlを補正量として上乗せして加えた。)。1時間撹拌した後、例示化合物2−1 18.6gを10minで滴下し1時間撹拌した。この間、内温は−10℃〜5℃であった。THF 480ml、例示化合物6−7 15.6g、炭酸カリウム 18.8gを純水 30mlに溶解した溶液の順に投入し窒素バブリングを20分間行った。この懸濁液にPd(dba)2 2.7g、例示化合物10−1 1.8gを加え6時間還流した。水冷で5時間撹拌し析出した結晶を濾過、水洗、乾燥し、灰色結晶 17.8gを得た(収率75.2%、純度99.2%)。 In a nitrogen stream, 16.9 g (0.10 mol) of Exemplified Compound 1-2 is dissolved in 390 m of dehydrated THF, adjusted to −5 ° C. with an ice water bath, and 59.4 ml of 1.6 M nBuLi (× 0.95 mol ratio to Exemplified Compound 1 (The water content of THF was 15 ppm when measured by coulometric titration. This corresponds to a corresponding amount of 1.6 M nBuLi solution per 3.25 × 10 −4 mol of water molecules. 0.20 ml was added as a correction amount. After stirring for 1 hour, 18.6 g of the exemplified compound 2-1 was added dropwise over 10 minutes, and the mixture was stirred for 1 hour. During this time, the internal temperature was -10 ° C to 5 ° C. A solution of 480 ml of THF, 15.6 g of the exemplified compound 6-7, and 18.8 g of potassium carbonate dissolved in 30 ml of pure water was sequentially charged, and nitrogen bubbling was performed for 20 minutes. To this suspension, 2.7 g of Pd (dba) 2 and 1.8 g of the exemplified compound 10-1 were added, and the mixture was refluxed for 6 hours. The mixture was stirred for 5 hours under water cooling, and the precipitated crystals were filtered, washed with water and dried to obtain 17.8 g of gray crystals (yield 75.2%, purity 99.2%).
実施例14(本発明)
《例示化合物7−11の合成》
Example 14 (Invention)
Synthesis of Exemplified Compound 7-11
窒素気流下、例示化合物1−16 18.6g(0.10mol)を脱水THF 390mに溶解し、氷水浴で−5℃とし、1.6M nBuLi 59.4ml(×0.95mol比 対例示化合物1−16)を10minで滴下した(THFの含水量を電量滴定法で測定したところ150ppmであった。これは、水分子 3.25×10−3molに当たり、相当する量の1.6M nBuLi溶液 2.0mlを補正量として上乗せして加えた。)。1時間撹拌した後、例示化合物2−8 17.2gを10minで滴下し1時間撹拌した。この間、内温は−10℃〜5℃であった。THF 480ml、例示化合物6−3 11.8g、炭酸カリウム 16.8gを純水 30mlに溶解した溶液の順に投入し窒素バブリングを20分間行った。この懸濁液にPd(dba)2 2.7g、例示化合物10−4 1.9gを加え6時間還流した。水冷で5時間撹拌し析出した結晶を濾過、水洗、乾燥し、灰色結晶 15.7gを得た(収率73.2%、純度99.1%)。 In a nitrogen stream, 18.6 g (0.10 mol) of Exemplified Compound 1-16 is dissolved in 390 m of dehydrated THF, adjusted to -5 ° C. with an ice water bath, and 59.4 ml of 1.6 M nBuLi (× 0.95 mol ratio to Exemplified Compound 1 (The water content of THF was measured by coulometric titration method and was 150 ppm. This corresponds to a corresponding amount of 1.6 M nBuLi solution per 3.25 × 10 −3 mol of water molecules. Added 2.0 ml as a correction amount). After stirring for 1 hour, 17.2 g of Exemplified compound 2-8 was added dropwise over 10 minutes and stirred for 1 hour. During this time, the internal temperature was -10 ° C to 5 ° C. A solution of 480 ml of THF, 11.8 g of Example Compound 6-3, and 16.8 g of potassium carbonate dissolved in 30 ml of pure water was sequentially charged, and nitrogen bubbling was performed for 20 minutes. To this suspension, 2.7 g of Pd (dba) 2 and 1.9 g of the exemplified compound 10-4 were added, and the mixture was refluxed for 6 hours. The precipitated crystals were filtered, washed with water and dried to obtain 15.7 g of gray crystals (yield: 73.2%, purity: 99.1%).
実施例中の各化合物の同定はMASSおよびNMRスペクトルで行い、それぞれ目的化合物であることを確認した。その他の例示化合物も上記の方法に準じて合成することができる。 Identification of each compound in the examples was performed by MASS and NMR spectra, and it was confirmed that each was the target compound. Other exemplified compounds can also be synthesized according to the above method.
以上のとおり、本発明の製造方法により、有機合成化合物の有用な中間体であるボレート化合物およびそれから誘導される含窒素複素環化合物は、高純度、高収率で得られる。また、本発明の製造方法により得られるボレート化合物およびそれから誘導される含窒素複素環化合物は、特に有機エレクトロルミネッセンス用材料として有用であり、優れた効果を有する。 As described above, according to the production method of the present invention, borate compounds which are useful intermediates of organic synthetic compounds and nitrogen-containing heterocyclic compounds derived therefrom can be obtained with high purity and high yield. In addition, the borate compounds obtained by the production method of the present invention and the nitrogen-containing heterocyclic compounds derived therefrom are particularly useful as materials for organic electroluminescence, and have excellent effects.
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017235424A JP2019099537A (en) | 2017-12-07 | 2017-12-07 | Method for producing nitrogen-containing heterocyclic compound |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017235424A JP2019099537A (en) | 2017-12-07 | 2017-12-07 | Method for producing nitrogen-containing heterocyclic compound |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2019099537A true JP2019099537A (en) | 2019-06-24 |
Family
ID=66975838
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017235424A Pending JP2019099537A (en) | 2017-12-07 | 2017-12-07 | Method for producing nitrogen-containing heterocyclic compound |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2019099537A (en) |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012102967A1 (en) * | 2011-01-24 | 2012-08-02 | Universal Display Corporation | Aza - dibenzothiophene, aza - dibenzofuran and aza - dibenzoselenophene derivatives for use in oled ' s |
WO2013140417A1 (en) * | 2012-03-19 | 2013-09-26 | Council Of Scientific & Industrial Research | BORONIC ACID BEARING LIPHAGANE COMPOUNDS AS INHIBITORS OF PI3K-α AND/OR β |
WO2014044722A1 (en) * | 2012-09-20 | 2014-03-27 | Basf Se | Azadibenzofurans for electronic applications |
JP2014127687A (en) * | 2012-12-27 | 2014-07-07 | Canon Inc | Organic light-emitting element |
JP2015122255A (en) * | 2013-12-25 | 2015-07-02 | コニカミノルタ株式会社 | Transparent electrode and electronic device |
WO2016022624A1 (en) * | 2014-08-06 | 2016-02-11 | California Institute Of Technology | Silylation of aromatic heterocycles by earth abundant transition-metal-free catalysts |
JP2016069377A (en) * | 2014-09-30 | 2016-05-09 | 株式会社半導体エネルギー研究所 | Organometallic complex, light-emitting element, light-emitting device, electronic device and lighting device |
JP2016082205A (en) * | 2014-10-22 | 2016-05-16 | 三星ディスプレイ株式會社Samsung Display Co.,Ltd. | Material for organic electroluminescent element and organic electroluminescent element including the same |
US20160240800A1 (en) * | 2015-02-13 | 2016-08-18 | Universal Display Corporation | Organic electroluminescent materials and devices |
WO2018079459A1 (en) * | 2016-10-25 | 2018-05-03 | コニカミノルタ株式会社 | Organic electroluminescence element and material for organic electroluminescence |
-
2017
- 2017-12-07 JP JP2017235424A patent/JP2019099537A/en active Pending
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012102967A1 (en) * | 2011-01-24 | 2012-08-02 | Universal Display Corporation | Aza - dibenzothiophene, aza - dibenzofuran and aza - dibenzoselenophene derivatives for use in oled ' s |
WO2013140417A1 (en) * | 2012-03-19 | 2013-09-26 | Council Of Scientific & Industrial Research | BORONIC ACID BEARING LIPHAGANE COMPOUNDS AS INHIBITORS OF PI3K-α AND/OR β |
WO2014044722A1 (en) * | 2012-09-20 | 2014-03-27 | Basf Se | Azadibenzofurans for electronic applications |
JP2014127687A (en) * | 2012-12-27 | 2014-07-07 | Canon Inc | Organic light-emitting element |
JP2015122255A (en) * | 2013-12-25 | 2015-07-02 | コニカミノルタ株式会社 | Transparent electrode and electronic device |
WO2016022624A1 (en) * | 2014-08-06 | 2016-02-11 | California Institute Of Technology | Silylation of aromatic heterocycles by earth abundant transition-metal-free catalysts |
JP2016069377A (en) * | 2014-09-30 | 2016-05-09 | 株式会社半導体エネルギー研究所 | Organometallic complex, light-emitting element, light-emitting device, electronic device and lighting device |
JP2016082205A (en) * | 2014-10-22 | 2016-05-16 | 三星ディスプレイ株式會社Samsung Display Co.,Ltd. | Material for organic electroluminescent element and organic electroluminescent element including the same |
US20160240800A1 (en) * | 2015-02-13 | 2016-08-18 | Universal Display Corporation | Organic electroluminescent materials and devices |
WO2018079459A1 (en) * | 2016-10-25 | 2018-05-03 | コニカミノルタ株式会社 | Organic electroluminescence element and material for organic electroluminescence |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI410413B (en) | Preparation method of methylene disulfonate compound | |
WO2009096202A1 (en) | Halogenated polycyclic aromatic compound and method for producing the same | |
EP1362040B1 (en) | Process for the preparation of mesylates of piperazine derivatives | |
WO2019188200A1 (en) | Production method for lithium sulfamate, and novel lithium sulfamate | |
EP3737678A1 (en) | Process for the preparation of disubstituted diaryloxybenzoheterodiazole compounds | |
Paramanik et al. | Catalytic nucleophilic fluorination by an imidazolium ionic liquid possessing trialkylphosphine oxide functionality | |
JP5880226B2 (en) | Method for producing polymerizable compound | |
JP2019099537A (en) | Method for producing nitrogen-containing heterocyclic compound | |
JP4667575B2 (en) | Process for producing 1,3-dialkylimidazolium iodine salt | |
JP2010120926A (en) | Polycyclic pentafluorosulfanylbenzene compound and method for producing the same | |
JPH10114691A (en) | Production of aromatic acetylene compound | |
JP2019524783A5 (en) | ||
CN102442947B (en) | Preparation method of Montelukast Sodium intermediate | |
JP2018135274A (en) | Method of producing fluoromethyl group-containing compound using polycyclic aromatic hydrocarbon as photocatalyst | |
JP5448572B2 (en) | Acetyl compound, method for producing the acetyl compound, and method for producing a naphthol compound using the acetyl compound | |
JP2008169161A (en) | Method for producing methylene disulfonate compound | |
JP4507398B2 (en) | Method for synthesizing 3-halomethyloxetane compounds | |
JP4663105B2 (en) | Method for producing 2-sulfonyl-4-oxypyridine derivative | |
KR102157528B1 (en) | Method for producing 2-aminonicotinic acid benzyl ester derivative | |
CN118026807A (en) | Process for preparing 1, 1-difluoro substituted-1, 3-eneyne compounds | |
JP4165110B2 (en) | Preparation of 4-oxypyrimidine derivatives | |
JP3799580B2 (en) | Process for producing N-substituted-N-sulfonylamides | |
JP4475901B2 (en) | Method for producing 3-acetylthiophenes | |
KR101590592B1 (en) | Manufacturing method of dipyrryl ketones and dipyrryl ketones made by the same | |
JP2580282B2 (en) | Method for producing polyoxacyclodiene compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200928 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20210708 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210810 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20220215 |